RADIORHENIUM ANTIBODIES FOR RADIOIMMUNOTHERAPY
IC Name
DIVISION OF CANCER TREATMENT
-
Activity
N44
-
Administering IC
CM
-
Application Type
5
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
-
Sub Project Total Cost
-
ARRA Funded
-
CFDA Code
395
-
Ed Inst. Type
-
Funding ICs
-
Funding Mechanism
-
Study Section
-
Study Section Name